Symbol="FDMT"
AssetType="Common Stock"
Name="4D Molecular TherapeuticsÂ Inc"
Description="4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops candidate products using its adeno-associated virus vectors. The company is headquartered in Emeryville, California."
CIK="1650648"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="5858 HORTON STREET #455, EMERYVILLE, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="757707000"
EBITDA="-110720000"
PERatio="None"
PEGRatio="None"
BookValue="6.58"
DividendPerShare="0"
DividendYield="0"
EPS="-3.45"
RevenuePerShareTTM="0.068"
ProfitMargin="0"
OperatingMarginTTM="-51.52"
ReturnOnAssetsTTM="-0.25"
ReturnOnEquityTTM="-0.427"
RevenueTTM="2208000"
GrossProfitTTM="-77124000"
DilutedEPSTTM="-3.45"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.756"
AnalystTargetPrice="38.63"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="378.9"
PriceToBookRatio="3.014"
EVToRevenue="277.01"
EVToEBITDA="-5.32"
Beta="2.354"
num_52WeekHigh="26.49"
num_52WeekLow="6.58"
num_50DayMovingAverage="18.66"
num_200DayMovingAverage="17.29"
SharesOutstanding="41885400"
DividendDate="None"
ExDividendDate="None"
symbol="FDMT"
open="18.05"
high="18.52"
low="17.80"
price="18.25"
volume="337721.00"
latest_trading_day="2023-07-07"
previous_close="18.09"
change="0.16"
change_percent="0.8845%"
aroon_positive_momentum_days="20"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="20"
Volume_recent_avg="560977"
Change_recent_avg="-0.02"
Delta_recent_avg="1.37"
Variance_recent_avg="0.68"
Change_ratio_recent_avg="-0.2"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="20"
Aroon_momentum_negative="80"
image_negative_thumbnail_id_1="1158"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0192.jpeg"
image_negative_thumbnail_id_2="1156"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0190.jpeg"
image_neutral_thumbnail_id_1="536"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0063.jpeg"
image_neutral_thumbnail_id_2="552"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0047.jpeg"
image_positive_thumbnail_id_1="991"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0153.jpeg"
image_positive_thumbnail_id_2="1000"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0162.jpeg"
image_professor_thumbnail_id_1="1181"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0015.jpeg"
image_professor_thumbnail_id_2="1184"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0018.jpeg"
